OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeted protein degradation directly engaging lysosomes or proteasomes
Jiseong Kim, Insuk Byun, Do Young Kim, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3253-3272
Open Access | Times Cited: 21
Jiseong Kim, Insuk Byun, Do Young Kim, et al.
Chemical Society Reviews (2024) Vol. 53, Iss. 7, pp. 3253-3272
Open Access | Times Cited: 21
Showing 21 citing articles:
Ferroptosis: principles and significance in health and disease
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Fangquan Chen, Rui Kang, Daolin Tang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 37
Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Lisha Ou, Mekedlawit Setegne, Jeandele Elliot, et al.
Chemical Reviews (2025)
Closed Access
Receptor-ligand interactions for optimized endocytosis in targeted therapies
Yejin Sung, Young‐Jin Choi, Eun Sun Kim, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 524-538
Open Access
Yejin Sung, Young‐Jin Choi, Eun Sun Kim, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 524-538
Open Access
Versatile One-Pot Synthesis of Hydrophobic Tags by Multicomponent Reactions
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025) Vol. 10, Iss. 5, pp. 4745-4753
Open Access
Federica Carolina Balestrero, Laura Gioiello, Georgia Goutsiou, et al.
ACS Omega (2025) Vol. 10, Iss. 5, pp. 4745-4753
Open Access
A Bifunctional Lysosome‐Targeting Chimera Nanoplatform for Tumor‐Selective Protein Degradation and Enhanced Cancer Immunotherapy
Yumeng Xing, Jingjing Li, Leyuan Wang, et al.
Advanced Materials (2025)
Closed Access
Yumeng Xing, Jingjing Li, Leyuan Wang, et al.
Advanced Materials (2025)
Closed Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
Systematic evolution of functional oligonucleotides for targeted protein degradation
Huang Su, Yifan Chen, Xuyang Zhao, et al.
Chem (2025), pp. 102408-102408
Closed Access
Huang Su, Yifan Chen, Xuyang Zhao, et al.
Chem (2025), pp. 102408-102408
Closed Access
Proteolysis-Targeting Chimera-Doxorubicin Conjugate Nanoassemblies for Dual Treatment of EGFR-TKI Sensitive and Resistant Non-Small Cell Lung Cancer
Junhui Ma, Ruixue Zhu, Meijing Li, et al.
Acta Biomaterialia (2025)
Closed Access
Junhui Ma, Ruixue Zhu, Meijing Li, et al.
Acta Biomaterialia (2025)
Closed Access
Small molecule targeted protein degradation via the UPS: venturing beyond E3 substrate receptors
Renyu Guo, Fukang Yang, Emily C. Cherney
RSC Medicinal Chemistry (2025)
Closed Access
Renyu Guo, Fukang Yang, Emily C. Cherney
RSC Medicinal Chemistry (2025)
Closed Access
Redox regulation: mechanisms, biology and therapeutic targets in diseases
Bowen Li, Hui Ming, Siyuan Qin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Bowen Li, Hui Ming, Siyuan Qin, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins
Yuxin Fang, Yaojin Zhu, Wei Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Yuxin Fang, Yaojin Zhu, Wei Wang, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access
Transforming Therapeutic Approaches with PROTAC Technology: New Targets and Potentials
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 573-575
Open Access | Times Cited: 2
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 573-575
Open Access | Times Cited: 2
Next steps for targeted protein degradation
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 2
Mackenzie W. Krone, Craig M. Crews
Cell chemical biology (2024)
Closed Access | Times Cited: 2
Expanding TPD Horizons: Innovative Strategies Targeting BCL6 and SMARCA2
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 576-578
Open Access | Times Cited: 1
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 5, pp. 576-578
Open Access | Times Cited: 1
A photoactivatable upconverting nanodevice boosts the lysosomal escape of PROTAC degraders for enhanced combination therapy
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 1
Jiayin Zhan, Xiang Li, Yueru Mu, et al.
Biomaterials Science (2024) Vol. 12, Iss. 14, pp. 3686-3699
Closed Access | Times Cited: 1
Unraveling the role of ubiquitin-conjugating enzyme 5 (UBC5) in disease pathogenesis: A comprehensive review
Jinjin Shi, Ru-Yi Chen, Yanjun Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111376-111376
Closed Access | Times Cited: 1
Jinjin Shi, Ru-Yi Chen, Yanjun Liu, et al.
Cellular Signalling (2024) Vol. 124, pp. 111376-111376
Closed Access | Times Cited: 1
To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Diana Castagna, Benoit Gourdet, Roland Hjerpe, et al.
Progress in medicinal chemistry (2024), pp. 61-160
Closed Access | Times Cited: 1
Lysosomal Degradation of Extracellular Targets: Innovations and Implications
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 752-754
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 6, pp. 752-754
Open Access
Dehydroabietylamine exerts antitumor effects by affecting nucleotide metabolism in gastric cancer
Jingsong Ma, Jiabao Zhao, Zhengxin Wu, et al.
Carcinogenesis (2024)
Open Access
Jingsong Ma, Jiabao Zhao, Zhengxin Wu, et al.
Carcinogenesis (2024)
Open Access
Aptamer‐based Immune Checkpoint Inhibition for Cancer Immunotherapy
Yihao Huang, Guihong Lin, Sinong Liu, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access
Yihao Huang, Guihong Lin, Sinong Liu, et al.
ChemBioChem (2024) Vol. 26, Iss. 1
Closed Access
Exploring heat shock proteins as therapeutic targets for Parkinson’s disease
Xiang Li, Wenjun Wang, Pan Shi, et al.
Biochemical Pharmacology (2024), pp. 116633-116633
Open Access
Xiang Li, Wenjun Wang, Pan Shi, et al.
Biochemical Pharmacology (2024), pp. 116633-116633
Open Access
Nanotechnology‐Enabled Targeted Protein Degradation for Cancer Therapeutics
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
Wutong Zhao, Yongbin Jiang, Xiufen Li, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 6
Closed Access
